Perilla protein polypeptide and application thereof in treatment of poultry infectious diseases
Perilla protein polypeptide prepared by enzymatic fig protease solves the problem that perilla protein resources are underdeveloped, and effective treatment of poultry infectious diseases is achieved, providing a safe and effective antibacterial drug selection.
Patent Information
- Application Number
- CN202411144884.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-20
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-08-20
AI Technical Summary
The prior art has failed to effectively utilize perilla protein resources, especially its potential applications in the treatment of infectious poultry diseases have not been fully developed.
Perilla protein enzymatically dissolved by fig protease, a perilla protein polypeptide with antibacterial effects was prepared and applied to the treatment of poultry infectious diseases caused by Staphylococcus aureus, Enterococcus chicken and Salmonella chicken. Prepare with appropriate auxiliary materials Oral medication.
Perilla protein peptide significantly improves the antibacterial effect on a variety of poultry pathogenic bacteria, provides a new, safe and effective treatment option for poultry infectious diseases. Its raw materials are food-grade resources and have good safety guarantees.
Smart Images

Figure CN118909041A_ABST
Abstract
Description
Field of the Invention
[0001] The present application belongs to the field of proteins and anti-infective drugs. Specifically, the present application provides a perilla protein polypeptide and its application in treating poultry infectious diseases. Background Art
[0002] Perilla is a herbaceous plant of the genus Perilla in the family Lamiaceae, mainly distributed in East Asia and South Asia. Perilla has a long history of medicinal and edible use, and can be used to prepare oils and spices. In traditional Chinese medicine, it is believed to have the effects of dispelling cold, promoting qi and relieving fullness, and calming the fetus. Modern medical research has found that perilla and many of its ingredients have antibacterial and anti-inflammatory, anti-tumor, and analgesic effects.
[0003] The most common use of perilla is oil extraction. The perilla meal left after oil extraction contains a large amount of perilla protein, which is currently mainly used as feed and fertilizer, or even abandoned. Based on the known medicinal uses of perilla, deep processing and functional exploration of perilla protein is a feasible way to further develop perilla as a plant resource. Summary of the invention
[0004] In view of the above situation, in order to further develop the application of perilla protein in the treatment of poultry diseases, on the one hand, the present application provides a perilla protein polypeptide, which is obtained by enzymatic hydrolysis of perilla protein with ficin.
[0005] Furthermore, the preparation method of the perilla protein is: crush the defatted perilla meal and add it into water with a mass 20 times that of the defatted perilla meal, mix; adjust the pH to 10; treat in a 60-70°C water bath for 1 hour; centrifuge to obtain the supernatant; adjust the pH of the supernatant to 4.5; centrifuge to obtain the precipitate; wash the precipitate with water and then freeze-dry to obtain the perilla protein.
[0006] Furthermore, the enzymatic hydrolysis method comprises: using water as a solvent to prepare an enzymatic hydrolysis composition comprising 100 mg / mL perilla protein, 500 U / mL ficin, 5 mg / mL Tween 20 or Span 20, and pH 5.5-6.5; and enzymatically hydrolyzing the enzymatic hydrolysis composition at 40-50° C. for 4-5 hours.
[0007] Furthermore, the perilla protein polypeptide is a polypeptide having a sequence as shown in SEQ ID NO.1 or SEQ ID NO.2.
[0008] On the other hand, the present application provides the use of the above-mentioned perilla protein polypeptide in the preparation of a drug for treating poultry infectious diseases.
[0009] Furthermore, the poultry infectious disease is caused by Staphylococcus aureus infection.
[0010] Furthermore, the poultry infectious disease is caused by Enterococcus gallus infection.
[0011] Furthermore, the poultry infectious disease is caused by infection with Salmonella Gallinarum.
[0012] Preferably, the poultry infectious disease is a chicken infectious disease. The chicken may be a broiler or a laying hen.
[0013] On the other hand, the present application provides a drug for treating infectious diseases in poultry, wherein the drug comprises the above-mentioned perilla protein polypeptide.
[0014] Furthermore, the drug is an oral drug.
[0015] Furthermore, the medicine also includes excipients acceptable in veterinary drugs.
[0016] Those skilled in the art can determine the specific types of acceptable excipients in the veterinary drugs based on veterinary medicine books and relevant regulatory provisions for veterinary drugs and poultry products, including but not limited to fillers, dispersants, adhesives, lubricants, flavoring agents, coating agents, solvents, co-solvents, pH adjusters, osmotic pressure regulators, etc.
[0017] The raw material of the perilla protein polypeptide of the present application is the food raw material perilla, which is safe and has potential Chinese medicine effects such as dispelling cold, promoting qi and soothing the stomach. The perilla protein polypeptide has obvious antibacterial effects on a variety of Gram-negative and Gram-positive avian pathogens including Enterococcus gallus, Staphylococcus aureus, and Salmonella gallus, providing a new class of drug options for the treatment of a variety of poultry infectious diseases. BRIEF DESCRIPTION OF THE DRAWINGS
[0018] Figure 1 This is the mass spectrum of the synthesized ZS-1.
[0019] Figure 2 This is the mass spectrum of synthesized ZS-2. DETAILED DESCRIPTION
[0020] How to measure antimicrobial performance:
[0021] The strains used included Enterococcus gallinarum (CGMCC 1.9125, G+), Staphylococcus aureus (CGMCC 1.2386, G+), and Salmonella gallinarum (ATCC 13036, G-).
[0022] The initial screening used the inhibition zone method: punch wells on the LB plates prepared for each strain, add 50 μL of a 20 mg / mL protein solution to each well, culture at 37°C for 24 hours, and observe the presence and size of the inhibition zone.
[0023] Minimum inhibitory concentration test: adjust the bacterial suspension of each strain in the logarithmic growth phase to 1×10 6CFU / mL, 100 μL of bacterial solution, as well as 2, 4, 8, 16, 32, 64, 128, 256, 512, 1024, 2048 μg / mL of antimicrobial peptide / protein solution and antibiotic positive control and negative control were added to each well, and OD600 was measured after incubation at 37°C for 12 hours.
[0024] Example 1 Preparation of Perilla Protein
[0025] Perilla protein was produced using defatted perilla meal from a certain oil production enterprise as raw material. The defatted perilla meal was crushed and added into water with a mass of 20 times that of the defatted perilla meal, mixed; the pH was adjusted to 10; the mixture was treated in a 60-70℃ water bath for 1 hour; the supernatant was centrifuged; the pH of the supernatant was adjusted to 4.5; the precipitate was centrifuged; the precipitate was washed with water and freeze-dried to obtain perilla protein.
[0026] Example 2 Enzymatic Hydrolysis of Perilla Protein
[0027] The perilla protein obtained in Example 1 was enzymatically hydrolyzed using papain, bromelain, ficin, and trypsin (Xiasheng, food grade), and the specific conditions were as follows:
[0028] Table 1 Enzymatic hydrolysis conditions
[0029]
[0030] The results showed that under the experimental conditions, the undigested perilla protein had only a small inhibition zone against Staphylococcus aureus. Among the hydrolyzed perilla proteins, trypsin was similar to that of the undigested ones, and bromelain hydrolyzates increased the resistance to Enterococcus gallinarum. Only the hydrolyzed products of fig protease had a relatively obvious antibacterial zone against the three bacteria. Therefore, the hydrolyzed products of fig protease were selected for further study of the hydrolysis conditions.
[0031] Considering that the raw material perilla is rich in oil, the aggregation mode of protein in aqueous solution may vary a lot. The applicant added surfactant (domestic, food grade) to the enzymatic hydrolysis system:
[0032] Table 2 Improved enzymatic hydrolysis conditions
[0033]
[0034] The MIC results of the enzymatic hydrolysates are shown in Table 3
[0035] Table 3 MIC test results of enzymatic hydrolysates
[0036]
[0037] The results showed that the addition of Tween or Span did promote the enzymatic hydrolysis process and improve the antibacterial properties of the enzymatic hydrolysates.
[0038] Example 3 Identification, synthesis and antimicrobial effect verification of antimicrobial peptides
[0039] In consideration of stable properties, resistance to digestion, and ease of preparation, the target product is a short peptide with a smaller molecular weight, so the enzymatic hydrolysate is centrifuged using a 3kDa ultrafiltration tube to obtain a perilla protein polypeptide less than 3kDa.
[0040] After the above-mentioned small molecule perilla protein polypeptide was desalted by column, it was separated and identified by LC-MS / MS method: the liquid phase was Shimadzu LC-20AD (self-assembled C18 column 75μm×25cm; mobile phase 1: 2% ACN, 0.2% formic acid, mobile phase 2: 98% CAN, 0.2% formic acid; column flow rate was 300nL / min, column temperature was 40°C), directly connected to a mass spectrometer (Thermo Fisher MALDI-TOP, primary scanning range: 200-1800m / z, AGC target: 3e 6 , resolution: 70000, maximum injection time: 50ms):
[0041] Mass spectrometry results were analyzed using MaxQuant 1.5.3.30 and identified using Mascot 2.3.02. R3 (Random Forest Algorithm), and antiBP2 database (Support Vector Machine Algorithm) were used to predict the antimicrobial peptides, and a total of three perilla protein peptides predicted to be antimicrobial peptides were obtained. After using ToxinPrep (Support Vector Machine Algorithm) to predict toxicity and synthesis difficulty, one was excluded, and the remaining two were ZS-1 (AIRKNLL, SEQ ID NO.1, molecular weight 827.02) and ZS-2 (ELGLSN, SEQ ID NO.2, molecular weight 631.67), both of which were ideal in potential toxicity and digestibility, and their solubility was also acceptable.
[0042] NovoPro solid phase resin method (Fmoc) was commissioned to synthesize ZS-1 and ZS-2 (mass spectra are shown in Figure 1 and Figure 2 The MIC of the two antimicrobial peptides was further tested, and the results are shown in Table 4:
[0043] Table 4 MIC test results of synthetic antimicrobial peptides
[0044] Antimicrobial peptides Enterococcus gallinarum Staphylococcus aureus Salmonella Gallinarum ZS-1: AIRKNLL 32 16 16 ZS-2:ELGLSN 32 8 16
[0045] The results showed that compared with the enzymatic hydrolysate, the two peptides can also achieve significant antibacterial effects at much higher concentrations, and are effective against three typical poultry Gram-positive and Gram-negative bacteria. Considering the low synthesis price of the two peptides (about 500 yuan per 50 mg in the experimental stage), they are expected to be used alone as antibacterial drugs in poultry farming.
Claims
1. A perilla protein polypeptide, characterized in that The perilla protein polypeptide is obtained by enzymatically hydrolyzing perilla protein with ficin.
2. The perilla protein polypeptide according to claim 1, wherein the preparation method of the perilla protein is: crushing the defatted perilla meal and adding it into water with a mass 20 times that of the defatted perilla meal, mixing; adjusting the pH to 10; treating in a 60-70° C. water bath for 1 hour; centrifuging to obtain the supernatant; adjusting the pH of the supernatant to 4.5; centrifuging to obtain a precipitate; washing the precipitate with water and freeze-drying it to obtain the perilla protein.
3. The perilla protein polypeptide according to claim 1 or 2, wherein the enzymatic hydrolysis method comprises: using water as a solvent to prepare an enzymatic hydrolysis composition comprising 100 mg / mL perilla protein, 500 U / mL ficin, 5 mg / mL Tween 20 or Span 20, and pH 5.5-6.5; and enzymatically hydrolyzing the enzymatic hydrolysis composition at 40-50° C. for 4-5 hours.
4. The perilla protein polypeptide according to claim 1, wherein the perilla protein polypeptide is a polypeptide having a sequence as shown in SEQ ID NO.1 or SEQ ID NO.
2.
5. Use of the perilla protein polypeptide according to any one of claims 1 to 4 in the preparation of a medicament for treating poultry infectious diseases.
6. The use according to claim 5, wherein the poultry infectious disease is caused by Staphylococcus aureus infection.
7. The use according to claim 5, wherein the poultry infectious disease is caused by infection with Enterococcus gallinarum.
8. The use according to claim 5, wherein the poultry infectious disease is caused by infection with Salmonella Gallinarum.
9. A drug for treating infectious diseases in poultry, characterized in that: The medicine comprises the perilla protein polypeptide according to any one of claims 1 to 4. The drug according to claim 9, which is an oral drug.
Citation Information
Patent Citations
Purple perilla seed anti-oxidizing heptapeptide and preparation method of same
CN106243191A
Anti-tumor perilla polypeptide and preparation method and application thereof
CN109628535A
Method for preparing perilla peptide
CN109757600A
Perilla seed peptide powder as well as preparation method and application thereof
CN112646000A
